據報蘋果(AAPL.US)研究引入長江儲存等iPhone晶片供應商
《彭博通訊社》報道,蘋果(AAPL.US)正研究增加新的iPhone晶片供應商,於湖北的長江儲存或成為首間供應iPhone晶片的中國供應商。
上月鎧俠(Kioxia Holdings)在日本兩座工廠因原料污染而影響生產,導致蘋果考慮增加更多供應商,當中包括美光(MU.US)及三星等,據悉蘋果已在測試長江儲存生產的NAND晶片。
消息人士稱,暫時未知長江儲存能否成為蘋果的供應商,由於長江儲存的技術至少落後一代,相信最多只能成為蘋果主要供應商SK海力士及三星的後備選擇。即使蘋果對長江儲存的晶片進行認證,但亦需要證明其產量及質量是具有可靠性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.